Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -146,412 | -162,857 | -146,398 | 158,519 | 153,464 |
| Depreciation Amortization | 28,821 | 96,998 | 30,894 | 33,102 | 17,250 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,018 |
| Accounts receivable | N/A | N/A | N/A | 129,171 | 59,864 |
| Accounts payable and accrued liabilities | 3,457 | 10,635 | -15,104 | -2,094 | -3,237 |
| Other Working Capital | -70,694 | -25,843 | 13,225 | 29,825 | 41,672 |
| Other Operating Activity | 53,533 | -27,489 | 73,506 | -71,163 | -22,411 |
| Operating Cash Flow | $-131,295 | $-108,556 | $-43,877 | $277,360 | $244,584 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 103,296 | 172,796 | -110,573 | -253,351 | -247,102 |
| PPE Investments | -42,772 | -78,396 | -76,947 | -70,660 | -58,452 |
| Net Acquisitions | 30,113 | N/A | N/A | N/A | -11,457 |
| Purchase Of Investment | -24,230 | -8,699 | -58,899 | -43,048 | -47,857 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -2,000 | 0 |
| Other Investing Activity | 21,343 | 35,708 | 25,311 | 14,434 | 32,621 |
| Investing Cash Flow | $87,750 | $121,409 | $-221,108 | $-352,625 | $-332,247 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,731 | 13,498 | 11,590 | 2,755 | 5,487 |
| Other Financing Activity | -15,649 | -729 | -1,234 | -4,383 | -9,373 |
| Financing Cash Flow | $14,082 | $12,769 | $10,356 | $-1,628 | $-3,886 |
| Exchange Rate Effect | 1,097 | -2,617 | 589 | -9,599 | -1,425 |
| Beginning Cash Position | 183,615 | 160,610 | 414,650 | 501,142 | 594,116 |
| End Cash Position | 155,249 | 183,615 | 160,610 | 414,650 | 501,142 |
| Net Cash Flow | $-28,366 | $23,005 | $-254,040 | $-86,492 | $-92,974 |
| Free Cash Flow | |||||
| Operating Cash Flow | -131,295 | -108,556 | -43,877 | 277,360 | 244,584 |
| Capital Expenditure | -42,772 | -78,396 | -76,947 | -70,660 | -58,452 |
| Free Cash Flow | -174,067 | -186,952 | -120,824 | 206,700 | 186,132 |